1994
DOI: 10.1677/joe.0.1410001
|View full text |Cite
|
Sign up to set email alerts
|

Growth hormone-binding proteins: state of the art

Abstract: The discovery of growth hormone-binding proteins (GHBP) in the mid-1980s has provided considerable impetus to the elucidation of growth hormone (GH) action. The unexpected finding of a circulating GH 'receptor' \p=n-\the high-affinity GHBP \p=n-\in serum has facilitated assessment of GH receptor status in humans through a simple venipuncture, whereas previously GH receptors could only be reliably quantified in liver. Although it remains to be rigorously proven that the GHBP level in serum reflects tissue GH re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

1996
1996
2018
2018

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(27 citation statements)
references
References 52 publications
1
25
0
Order By: Relevance
“…Regulation of the GH receptor (GHR) is also an important mechanism of control within the somatotrophic axis. The GH binding protein (GHBP), a second product of the GHR gene corresponding to the extracellular domain of the GHR, may also regulate GH action both at an endocrine and at a local level (Baumann 1994). In rodents, the liver is the primary source of GHBP in plasma, although most non-hepatic tissues also express GHBP mRNA (Tiong & Herington 1991).…”
Section: Introductionmentioning
confidence: 99%
“…Regulation of the GH receptor (GHR) is also an important mechanism of control within the somatotrophic axis. The GH binding protein (GHBP), a second product of the GHR gene corresponding to the extracellular domain of the GHR, may also regulate GH action both at an endocrine and at a local level (Baumann 1994). In rodents, the liver is the primary source of GHBP in plasma, although most non-hepatic tissues also express GHBP mRNA (Tiong & Herington 1991).…”
Section: Introductionmentioning
confidence: 99%
“…IGFBP-1 is a potent inhibitor of the insulin-like activity of IGF-I (42); thus, the reduction in the ratio of IGF-I/IGFBP-1 in FHA may act as an energy-conserving strategy by minimizing the hypoglycemic action of IGF-I. GHBP concentrations, a reflection of the extracellular domain of hepatic GH receptors (43), were reduced 40% in FHA, consistent with more severe hypometabolic states, such as anorexia nervosa (34,44) and fasting (43).…”
Section: Discussionmentioning
confidence: 99%
“…This binding is reversible, and the growth hormone in the form of the GH-GHBP complex loses the ability to bind with the specific trans-membrane receptor, what results in the functional inactivation of the hormone (Baumann, 2009). On the other hand, the said complex protects the growth hormone from degradation and secretion from the system (Baumann, 1994).…”
Section: Mink Growth Hormone's Proteinmentioning
confidence: 99%